BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP — Canadian drug shortage status
Manufacturer: OMEGA LABORATORIES LIMITED
1 active report
Shortage reports for BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP filed with Health Canada's drug shortage register, as tracked by Nexara. Each row is one reported presentation or strength.
| Status | Strength / detail | Estimated resolution | Tier | Last seen | Source |
|---|---|---|---|---|---|
| active | 7.5MG | 2026-09-04 | healthproductshortages.ca |
Sourcing during a shortage
When a Canadian product is in shortage, Health Canada may permit exceptional importation of a foreign-authorized equivalent, and practitioners may apply through the Special Access Programme. Read how named-patient and foreign-pack supply works in Canada.
Request a quote for BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP